Extrovis

Extrovis is a fully integrated, Indo-Swiss global pharmaceutical company operating as a CRDMO (Contract Research, Development, and Manufacturing Organization). The company specializes in the development and manufacturing of niche and differentiated finished dosage forms (FDF), active pharmaceutical ingredients (APIs), and intermediates, with a focus on complex therapeutics including sterile antibiotics, cytotoxic formulations, and drug-device combinations. With a global footprint spanning Switzerland, India, and the US, Extrovis leverages state-of-the-art R&D centers and manufacturing facilities that comply with international quality standards, including accreditations from the USFDA, PMDA, and EU regulatory bodies. The company aims to address supply chain complexities and provide high-quality, accessible medicines from molecule to market for global pharmaceutical partners.